SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $65,987,000 | +61.4% | 337,204 | +40.2% | 2.47% | +58.9% |
| Q2 2020 | $40,876,000 | +65.1% | 240,559 | +12.1% | 1.56% | +39.1% |
| Q1 2020 | $24,752,000 | -21.7% | 214,530 | -22.5% | 1.12% | -6.4% |
| Q4 2019 | $31,623,000 | +27.7% | 276,766 | -4.5% | 1.20% | +10.7% |
| Q3 2019 | $24,760,000 | +23.4% | 289,925 | 0.0% | 1.08% | +31.9% |
| Q2 2019 | $20,066,000 | -5.5% | 289,925 | 0.0% | 0.82% | -5.0% |
| Q1 2019 | $21,234,000 | +65.6% | 289,925 | +28.1% | 0.86% | +57.0% |
| Q4 2018 | $12,819,000 | -40.5% | 226,239 | -19.0% | 0.55% | -29.8% |
| Q3 2018 | $21,549,000 | +16.2% | 279,417 | 0.0% | 0.78% | +11.1% |
| Q2 2018 | $18,550,000 | +2.3% | 279,417 | -19.4% | 0.70% | -0.1% |
| Q1 2018 | $18,136,000 | +51.5% | 346,499 | +54.9% | 0.70% | +52.6% |
| Q4 2017 | $11,968,000 | -1.7% | 223,700 | 0.0% | 0.46% | +6.2% |
| Q3 2017 | $12,172,000 | +5.2% | 223,700 | 0.0% | 0.44% | +1.4% |
| Q2 2017 | $11,574,000 | – | 223,700 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |